Ceruloplasmin and uses thereof in neurodegenerative related conditions
CA 2407781 A1 · Owner: Paquin, Joanne · Inventors: Mateescu, Mircea Alexandru; Maltais, Domynick; Paquin, Joanne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of ceruloplasmin (and/or derivatives thereof) for treating neurodegenerative related conditions. More particularly the present invention pertains to the use of ceruloplasmin in pharmaceutical neurotrophic compositions, to its use as a carrier for delivering therapeutic agent(s) to tissues of the nervous systems and to its use in methods for culturing neuronal cells in vitro. The present invention is useful for maintaining or stimulating the regeneration of neuronal cells particularly , for the treatment of injuries to the brain the spinal cord and other central , nervous system tissues.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 2, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.